Article Information
- Received June 21, 1996
- Revision received October 22, 1996
- Accepted October 24, 1996
- First published January 15, 1997.
- Version of record published January 15, 1997.
Author Information
Author contributions
Disclosures
- Received June 21, 1996.
- Revision received October 22, 1996.
- Accepted October 24, 1996.
This work was supported by grants to C.W.L. from the American Heart Association Florida affiliate, the Pharmaceutical Research and Manufacturers of America Foundation, and the National Institute on Drug Abuse (DA08102), and to D.J.A. from the National Heart, Lung, and Blood Institute (HL35422). C.W.L. was an Initial Investigator of the American Heart Association Florida affiliate. We thank Drs. Richard Bookman, Richard Kramer, and Jim Patrick for critical reading of this manuscript.
Correspondence should be addressed to Dr. Charles W. Luetje, Department of Molecular and Cellular Pharmacology (R-189), University of Miami School of Medicine, P.O. Box 016189, Miami, FL 33101.
Dr. Cuevas’s present address: Department of Biology, University of California, San Diego, CA 92093.
Dr. Adams’s present address: Department of Physiology and Pharmacology, University of Queensland, Brisbane QLD 4072, Australia.
Online Impact
